Notice of Intent to Sole Source-MPF-ZAI SOLUTIONS
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Food and Drug Administration (FDA) has issued a Notice of Intent to Sole Source to MPF-ZAI SOLUTIONS LLC for Center for Biologics Evaluation and Research (CBER) Scientific Data Abstraction and Information Management. The FDA intends to award a Firm-Fixed-Price Purchase Order, citing MPF-ZAI SOLUTIONS LLC as the only known responsible source. Other interested firms must submit their capabilities or proposals within 10 days of the notice publication.
Scope of Work
The intended contract is for Scientific Data Abstraction and Information Management services for the FDA's Center for Biologics Evaluation and Research (CBER). This involves data abstraction, leveraging proprietary database systems, specialized methodologies, and validated processes.
Contract & Timeline
- Type: Firm-Fixed-Price Purchase Order (intended)
- Set-Aside: None specified (Sole Source)
- Response Due: April 18, 2026 (for general notice closure)
- Response for Consideration: Within 10 days of April 9, 2026 (for firms desiring consideration)
- Published: April 9, 2026
Justification for Sole Source
The FDA justifies the sole source award under FAR Part 6.302-1 and 6.302-3, stating that MPF-ZAI SOLUTIONS LLC is uniquely qualified. This is due to their exclusive access to a proprietary database system, specialized methodologies, specific training, technical expertise, and validated processes. They also possess several years of experience working with the systems required for this project.
Action for Interested Parties
While this is not a request for competitive quotes, any responsible offeror may submit a quote for consideration. Firms interested in providing this service must fully identify their interest and capability, or submit a proposal, within 10 days of the notice's publication date (April 9, 2026). Responses should be sent via email to Natalie.Brown@fda.hhs.gov. A determination by the government not to compete is solely at their discretion.